The 2016 TB Summit: 21st - 23rd June 2016

Past Events

The 2016 TB Summit: 21st – 23rd June 2016

May 8, 2015 By Euroscicon Off

This annual three day event will explore new research into TB detection, treatment and vaccination as well as new developments in controlling and preventing Mycobacterium tuberculosis Infection.

With an informal academic atmosphere and international speakers, it is the perfect environment for debate and discussion.

Deadlines

The Deadline for abstract submissions for oral presentation is 10th March 2016

The early registration deadline is 20th April 2016

The Deadline for abstract submissions for poster presentation is 5th June 2016

Who Should Attend: This event welcomes those working within tuberculosis research and treatment, drug discovery, global health, physicians and those working on novel technologies related to TB detection and control.

THIS EVENT HAS FINISHED

THE FOLLOW UP EVENT IS

Fighting Back Against Infectious Diseases – 5th – 7th September 2017

The 2016 TB Summit has an open abstract session: Abstracts can be submitted on any subject related to Mycobacterium Tuberculosis

Talks Include

Talk Title	Speaker	Affiliation	Country
Communicating risks and benefits of preventive tuberculosis treatment for shared decision making	Dr. Claudia Dobler	University of New South Wales	Australia
On the identifiability of transmission dynamic models for infectious diseases	Dr. Jarno Lintusaari	Aalto University	Finland
Integrated interdisciplinary approaches to tackle extensively drug resistance in TB	Dr Sanjib Bhakta	University of London	United Kingdom
TB in healthcare workers	Professor Albert Nienhaus	University Medical Center Hamburg-Eppendorf	Germany
Host defence mechanisms during early stages of tuberculosis in zebrafish	Professor Annemarie H. Meijer	Leiden University	Netherlands
Intracellular growth of Mycobacterium tuberculosis; linking microbial physiology to drug development.	Dr. Yossef Av-Gay	The University of British Columbia	Canada
Understanding and intervening in HIV-tuberculosis	Dr. Robert J Wilkinson	University of Cape Town	South Africa
Tuberculosis therapeutics that inhibit bacterial sensing and resistance to host immunity	Dr. Rob Abramovitch	Michigan State University	United States
A vaccine pipeline - phage display for biomarker identification and generation of human antibodies for diagnostics and therapy	Dr. Michael Hust	Universität Braunschweig	Germany
TBC	Dr Amador Goodridge	INDICASAT-AIP	Panama
Coughing and the transmission of tuberculosis	Dr. Richard Turner	Homerton University Hospital NHS Foundation Trust	United Kingdom
Extensive Drug Resistant Tuberculosis plus Linezolid Resistance: Linezolid resistance development in Lisbon, Portugal	Isabel Portugal	University of Lisbon	Portugal
TB persisters - resistance is futile, time to end them all	Dr. Yanmin Hu	St George's University of London	United Kingdom
Development of Dinitrobenzyl Oxadiazoles and Thiadiazoles as Selective Antitubercular Agents	Dr Jaroslav Roh	Charles University in Prague	Czech Republic
Design and synthesis of antitubercular small molecules targeting drug-resistant mycobacteria	Dr. Daniele Castagnolo	King's College London	United Kingdom
Development and deployment of new TB drugs	Dr. Gerry Davies	Liverpool, Liverpool	United Kingdom
TBC	Dr. Frédéric J. Veyrier	INRS-Institut Armand-Frappier	Canada
Recent Developments in Childhood Tuberculosis	Dr. James A Seddon	Imperial College London	United Kingdom
Adjunctive immunotherapy of tuberculosis using vitamin D and phenylbutyrate: a randomized double-blind clinical trial	Dr. Susanna Brighenti	Karolinska Institutet	Sweden
3 million TB cases missing: can community based services find them?	Professor Luis E. Cuevas	School of Tropical Medicine	United Kingdom
Assessment of terbium (III) as a probe for the detection of tuberculosis biomarkers	Dr. Thu-Hoa Tran-Thi	Centre national de la recherche scientifique	France
Capturing Geographic Complexity in a Homeless “Neighborhood”: spatial video geonarratives (SVG) in Skid Row, Los Angeles	Professor Andrew Curtis	Kent State University	United States
Understanding TB transmission with whole-genome sequencing and modelling	Dr. Caroline Colijn	Imperial College London	United Kingdom
Improvements in Energetics-Based Methods for Target Identification in TB Drug Discovery	Dr. Cristiano V. Bizarro	Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS	Brazil
The Mtb Divisome: Initial Structural Efforts on Drug Targets	Dr. Timothy A. Cross	Florida State University	United States
TBC	Professor Onn Min Kon	Imperial College Healthcare NHS Trust	United Kingdom
Plant natural products for TB treatment and prophylaxis	Dr. R. S. Santhosh	SASTRA University	India
Rapid differentiation of Mycobacteria	Dr Linda Stewart	Queen's University	United Kingdom
TBC	Professor Dirk Schnappinger	Weill Cornell Medical College	United States
TB or not TB? - Metabolomics may hold the answer	Professor Du Toit Loots	North-West University	South Africa
TaqMan Array Card for genotypic drug resistance testing	Professor Eric R. Houpt	University of Virginia	United States
TBC	Dr Dimitrios Evangelopoulos	University College London	United Kingdom
The role of human gamma/delta T cells in the immunity against the infection of Mycobacterium tuberculosis.	Dr. Baiqing Li	Bengbu Medical College	China
PURE-TB-LAMP: Simple & Rapid screenging test for TB	Dr Yasuyoshi Mori, Eike	Chemical Co.,Ltd	Japan
Genomes, structural biology and drug discovery: Understanding antimicrobial resistance in tuberculosis	Professor Tom Blundell	University of Cambridge	United Kingdom
TBC	Dr. Ill Young Lee	Korea Research Institute of Chemical Technology	South Korea
Plants a source of antitubercular agents	Dr. Maria del Rayo Camacho-Corona	Universidad Autónoma de Nuevo León	Mexico
Transcriptional Regulation in Mycobacteria	Dr. Eric Galburt, Washington	University School of Medicine	United States
Innate immune recognition of pathogenic mycobacteria	Dr. Antje Blumenthal	The University of Queensland Diamantina Institute	Australia
Toxin:antitoxin modules as regulators of TB growth and persistence	Associate Professor Shaleen Korch	Midwestern University	United States
"Bring me back to life" - resuscitation of dormant mycobacteria.	Dr. Galina Mukamolova	niversity of Leicester	United Kingdom
Purinergic signaling in the immune response to severe tuberculosis	Professor Maria Regina D'Imperio Lima	Universidade de São Paulo	Brazil
IFITM family members restrict Mycobacterium tuberculosis infection	Dr Shahin Ranjbar	Harvard Medical School	United States
TBC	Dr Prakash Udhawdas Tahiliani	Prime Ever Ayurvedic Research Laboratories	India
Multiple Biomarkers for Reliable Identification of Mycobacterium Tuberculosis Complex in Broth Culture Media with Nanodiamond	Professor Peng Wen-Ping	National Dong Hwa University	Taiwan
De novo design of short synthetic membrane-targeting anti-mycobacterial peptides.	Jasmeet Singh Khara	Imperial College London	United Kingdom
Next Generation Tuberculosis Diagnostics: Test and Treat	Dr. Elisa Tagliani	Emerging Bacterial Pathogens Unit	Italy
A vaccine pipeline: phage display for identification of vaccine candidates, and generation of human antibodies for diagnostics and therapy	Dr. Gustavo Moreira	Technische Universität Braunschweig	Germany

Advisory Board Members

Member	Affiliation	Country
Dr Tomoshige Matsumoto	Osaka Anti-Tuberculosis Association	Japan
Professor Edith Sim	University of Oxford	United Kingdom
Mr Michel Baltas	CNRS	France
Dr Sandrine Lesellier	Animal and Plant Health Agency (APHA)	United Kingdom
Professor P K Das	University of Amsterdam	The Netherlands